Won-Tae Cha
Vermögen: 18 Mio $ am 31.08.2026
Vermögen: 18 Mio $ am 31.08.2026
Won-Tae Cha currently works at Cha Biotech Co., Ltd., as Chief Executive Officer from 2026, Cha Medical & Bio Group, as Vice Chairman, and Stem Cell & Regenerative Medicine International, Inc., as Director.
Mr. Cha received his undergraduate degree from Duke University, Masters Business Admin degree from Massachusetts Institute of Technology, graduate degree from Yale University, and doctorate degree from Yonsei University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CHA BIOTECH CO., LTD. 3,34 % | 09.09.2026 | 3.110.518 ( 3,34 % ) | 18 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CHABIOTECH CO.,LTD. | Vorstandsvorsitzender | 04.03.2026 |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cha Biotech Co., Ltd.
Cha Biotech Co., Ltd. Electronic ComponentsElectronic Technology Manufactures and designs optical, digital, and medical products and related cell therapy and biological products | Electronic Technology |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen